Opa Vajragupta

2.2k total citations
82 papers, 1.8k citations indexed

About

Opa Vajragupta is a scholar working on Molecular Biology, Pharmacology and Physiology. According to data from OpenAlex, Opa Vajragupta has authored 82 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 22 papers in Pharmacology and 19 papers in Physiology. Recurrent topics in Opa Vajragupta's work include Curcumin's Biomedical Applications (17 papers), Cholinesterase and Neurodegenerative Diseases (13 papers) and Nicotinic Acetylcholine Receptors Study (13 papers). Opa Vajragupta is often cited by papers focused on Curcumin's Biomedical Applications (17 papers), Cholinesterase and Neurodegenerative Diseases (13 papers) and Nicotinic Acetylcholine Receptors Study (13 papers). Opa Vajragupta collaborates with scholars based in Thailand, United States and Japan. Opa Vajragupta's co-authors include Preecha Boonchoong, Michihisa Tohda, Yaowared Sumanont, Pornchai Rojsitthisak, Chantana Boonyarat, Yukihisa Murakami, Kinzo Matsumoto, Valery V. Fokin, Pasarapa Towiwat and Arthur J. Olson and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Opa Vajragupta

81 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Opa Vajragupta Thailand 22 677 449 413 354 269 82 1.8k
Chelliah Selvam United States 25 866 1.3× 325 0.7× 423 1.0× 197 0.6× 78 0.3× 52 1.8k
Valeria Pittalà Italy 35 1.9k 2.8× 189 0.4× 552 1.3× 413 1.2× 152 0.6× 132 3.2k
Yu Zhao China 27 1.4k 2.1× 266 0.6× 370 0.9× 290 0.8× 161 0.6× 98 2.3k
Barbara La Ferla Italy 30 1.3k 1.9× 184 0.4× 905 2.2× 282 0.8× 514 1.9× 108 2.5k
Richard T. Carroll United States 24 723 1.1× 113 0.3× 242 0.6× 241 0.7× 427 1.6× 42 1.9k
Pornchai Rojsitthisak Thailand 28 596 0.9× 451 1.0× 404 1.0× 261 0.7× 166 0.6× 105 1.9k
Mükerrem Betül Yerer Türkiye 20 1.1k 1.7× 128 0.3× 195 0.5× 249 0.7× 212 0.8× 79 2.5k
Joana A. Loureiro Portugal 28 1.1k 1.6× 189 0.4× 138 0.3× 326 0.9× 684 2.5× 84 2.8k
Mohammed Albratty Saudi Arabia 26 668 1.0× 66 0.1× 255 0.6× 245 0.7× 192 0.7× 113 2.1k
Manjula Vinayak India 24 665 1.0× 207 0.5× 179 0.4× 88 0.2× 166 0.6× 53 1.5k

Countries citing papers authored by Opa Vajragupta

Since Specialization
Citations

This map shows the geographic impact of Opa Vajragupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Opa Vajragupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Opa Vajragupta more than expected).

Fields of papers citing papers by Opa Vajragupta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Opa Vajragupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Opa Vajragupta. The network helps show where Opa Vajragupta may publish in the future.

Co-authorship network of co-authors of Opa Vajragupta

This figure shows the co-authorship network connecting the top 25 collaborators of Opa Vajragupta. A scholar is included among the top collaborators of Opa Vajragupta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Opa Vajragupta. Opa Vajragupta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suksamrarn, Apichart, et al.. (2024). Synthesis, Cytotoxicity, and Mechanistic Evaluation of Tetrahydrocurcumin-Amino Acid Conjugates as LAT1-Targeting Anticancer Agents in C6 Glioma Cells. International Journal of Molecular Sciences. 25(20). 11266–11266. 1 indexed citations
3.
Muangnoi, Chawanphat, et al.. (2023). An Integrative Approach to Investigate the Mode of Action of (−)-Dendroparishiol in Bacterial Meningitis: Computer-Aided Estimation of Biological Activity and Network Pharmacology. International Journal of Molecular Sciences. 24(9). 8072–8072. 2 indexed citations
4.
Jantaratana, Pongsakorn, et al.. (2023). Lutein-loaded chitosan/alginate-coated Fe3O4 nanoparticles as effective targeted carriers for breast cancer treatment. International Journal of Biological Macromolecules. 242(Pt 1). 124673–124673. 33 indexed citations
6.
Deuther‐Conrad, Winnie, et al.. (2023). Selective α3β4 Nicotinic Acetylcholine Receptor Ligand as a Potential Tracer for Drug Addiction. International Journal of Molecular Sciences. 24(4). 3614–3614. 2 indexed citations
7.
Jantaratana, Pongsakorn, et al.. (2023). Enhancing Physicochemical Properties and Biocompatibility of Hollow Porous Iron Oxide Nanoparticles through Polymer-Based Surface Modifications. ACS Applied Bio Materials. 6(12). 5426–5441. 12 indexed citations
8.
Vajragupta, Opa, et al.. (2023). Metformin and curcumin co-encapsulated chitosan/alginate nanoparticles as effective oral carriers against pain-like behaviors in mice. International Journal of Pharmaceutics. 640. 123037–123037. 12 indexed citations
9.
Sorasitthiyanukarn, Feuangthit Niyamissara, et al.. (2022). Folic Acid-Grafted Chitosan-Alginate Nanocapsules as Effective Targeted Nanocarriers for Delivery of Turmeric Oil for Breast Cancer Therapy. Pharmaceutics. 15(1). 110–110. 20 indexed citations
10.
Sorasitthiyanukarn, Feuangthit Niyamissara, et al.. (2022). Chitosan-coated nanostructured lipid carriers for transdermal delivery of tetrahydrocurcumin for breast cancer therapy. Carbohydrate Polymers. 288. 119401–119401. 70 indexed citations
11.
Chutiwitoonchai, Nopporn, et al.. (2022). Discovery of Natural Lead Compound from Dendrobium sp. against SARS-CoV-2 Infection. Pharmaceuticals. 15(5). 620–620. 4 indexed citations
13.
Vajragupta, Opa, et al.. (2021). Mechanistic Insight into the Effects of Curcumin on Neuroinflammation-Driven Chronic Pain. Pharmaceuticals. 14(8). 777–777. 30 indexed citations
14.
Tadtong, Sarin, et al.. (2021). Novel Multifunctional Ascorbic Triazole Derivatives for Amyloidogenic Pathway Inhibition, Anti-Inflammation, and Neuroprotection. Molecules. 26(6). 1562–1562. 12 indexed citations
15.
Vajragupta, Opa, et al.. (2021). Automated home-cage monitoring as a potential measure of sickness behaviors and pain-like behaviors in LPS-treated mice. PLoS ONE. 16(8). e0256706–e0256706. 12 indexed citations
17.
Vajragupta, Opa, et al.. (2020). Co-administration of Pregabalin and Curcumin Synergistically Decreases Pain-Like Behaviors in Acute Nociceptive Pain Murine Models. Molecules. 25(18). 4172–4172. 19 indexed citations
18.
Muangnoi, Chawanphat, et al.. (2020). Molecular Insight into the Anti-Inflammatory Effects of the Curcumin Ester Prodrug Curcumin Diglutaric Acid In Vitro and In Vivo. International Journal of Molecular Sciences. 21(16). 5700–5700. 35 indexed citations
19.
Regberg, Jakob, et al.. (2016). Role of scavenger receptors in peptide-based delivery of plasmid DNA across a blood–brain barrier model. International Journal of Pharmaceutics. 500(1-2). 128–135. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026